How much does a box of generic Osimertinib (Tagressa) cost?

Osimertinib (Tagrisso) is a drug widely used to treat non-small cell lung cancer (NSCLC). It belongs to a class of drugs called tyrosine kinase inhibitors, which act on the epidermal growth factor receptor (EGFR) in tumor cells. EGFR is a protein located on the surface of cells and is involved in regulating cell growth and division. However, in some patients with lung cancer, the EGFR gene is mutated, which promotes abnormal proliferation and growth of tumor cells, leading to the formation and spread of tumors.

Osimertinib (Tagressa) is now on the market in China and has also been included in the medical insurance system. Patients can purchase it directly from pharmacies in domestic hospitals at a price of about four to five thousand yuan. However, for specific selling prices and medical insurance reimbursement details, please consult your local hospital pharmacy for the most accurate information.

In addition, foreignosimertinib (Tagressa) generic drugs, especially the versions from Laos and Bangladesh, are more affordable and can be purchased for only a few hundred yuan, which has a significant price advantage compared to the domestic version. It is worth noting that the ingredients of these generic drugs are basically the same as the domestic Osimertinib (Tagrisso) original drug.

Osimertinib (Tagressa) is used to treat advanced NSCLC with EGFR mutations. Compared with traditional chemotherapy drugs, Osimertinib (Tagressa) has a more precise mechanism of action and can more effectively inhibit the growth and spread of tumor cells while reducing damage to healthy cells. Therefore, it is considered a targeted therapy drug.

One of the key advantages of osimertinib (Tagressa) is that it targets specific EGFR mutations, particularly the T790M T790M mutation that is ineffective with first- and second-generation EGFR inhibitors. T790Mmutation is one of the main reasons why advanced NSCLC patients become resistant to other EGFR inhibitors. Osimertinib (Tagressa)Being able to overcome this resistance allows patients to achieve longer survival and better quality of life.